FITC Anti-Mouse/Human CD44 Antibody[IM7]

FITC Anti-Mouse/Human CD44 Antibody[IM7]

Introducing the FITC Anti-Mouse/Human CD44 Antibody [IM7], a highly advanced and meticulously crafted product designed to cater to the discerning needs of scientific researchers and professionals in the field. This antibody, meticulously developed using cutting-edge technology, offers unparalleled specificity and sensitivity in detecting CD44, a cell surface glycoprotein involved in various physiological and pathological processes.

The FITC Anti-Mouse/Human CD44 Antibody [IM7] boasts an exceptional affinity for both mouse and human CD44, making it an invaluable tool for cross-species research and experimentation. Its fluorescein isothiocyanate (FITC) conjugation further enhances its utility by enabling direct visualization and analysis of CD44 expression in a wide range of biological samples.

With utmost precision and reliability, this antibody enables researchers to explore the intricate mechanisms underlying CD44-mediated cellular functions, including cell adhesion, migration, and signaling pathways. Its exceptional performance in flow cytometry, immunofluorescence, and immunohistochemistry techniques ensures accurate and reproducible results, empowering scientists to unravel the complexities of CD44 biology with utmost confidence.

The FITC Anti-Mouse/Human CD44 Antibody [IM7] is manufactured under stringent quality control measures, ensuring batch-to-batch consistency and reliability. Its exceptional purity and low background staining guarantee minimal interference, facilitating precise and unambiguous interpretation of experimental data.

In summary, the FITC Anti-Mouse/Human CD44 Antibody [IM7] stands as a pinnacle of scientific excellence, offering researchers an indispensable tool to unravel the mysteries of CD44 biology. With its unrivaled specificity, sensitivity, and versatility, this antibody promises to revolutionize the field and drive groundbreaking discoveries in various domains, including cancer research, immunology, and regenerative medicine.